Exenatide is a glucagon-like peptide‑1 (GLP‑1) receptor agonist used to improve blood sugar control in adults with type 2 diabetes, often in combination with other antidiabetic medications. It works by stimulating insulin secretion in response to high blood sugar, slowing gastric emptying, and reducing appetite. It is available as a twice‑daily injection (Byetta®) or a once‑weekly extended‑release suspension (Bydureon®). Common side effects include nausea, vomiting, diarrhea, headache, and injection site reactions.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
China [CN] 
Click enlarge Image